SC Filed 2024-10-15 Event — SEC 0000895345-24-000430 →

Boxer Capital, LLC → Tyra Biosciences, Inc. TYRA

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (15.3 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 15.33

9,495,754 shares short · +0.9% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $22.98M

Point72 Asset Mgmt

Other 13D/G Filings on Tyra Biosciences, Inc.

Filed	Form	Filer	Stake	Shares
2026-09-21	SCHEDULE 13G	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2026-09-17	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	14,130,492	view →
2026-09-17	SCHEDULE 13G	Paradigm Biocapital Advisors LP	—	—	view →

Other Filings by Boxer Capital, LLC

Filed	Form	Issuer	Stake	Shares
2023-12-18	SC	Rain Oncology Inc.	—	—	view →
2023-10-12	SC	Mirati Therapeutics, Inc.	—	—	view →
2022-01-06	SC	iTeos Therapeutics, Inc.	—	—	view →
2021-11-26	SC	Odonate Therapeutics, Inc.	—	—	view →
2021-11-22	SC	Odonate Therapeutics, Inc.	—	—	view →
2020-11-02	SC	Mirati Therapeutics, Inc.	—	—	view →
2020-09-01	SC	Odonate Therapeutics, Inc.	—	—	view →
2019-07-19	SC	Mirati Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →